Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ResPGlioma: Impact of PET-Guided Resection on Survival in High-Grade Gliomas - A Multicenter Prospective Study

NCT07567196 is registered in ClinicalTrials.gov with Universita degli Studi di Genova as lead sponsor.

NCT NCT07567196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07567196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ResPGlioma: Impact of PET-Guided Resection on Survival in High-Grade Gliomas - A Multicenter Prospective Study
Lead sponsor
Universita degli Studi di Genova
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2022
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioma glioblastoma multiforme, glioma surgery, glioma, high grade, positron-emission tomography(pet)